Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoki Niikura

Showing results (1-10 of 130) with videos related to

Pageof 13
Sort By:
Translational Cancer Research|February 4, 2022
Diagnosis of oligometastasisMayako Terao, Naoki Niikura
Journal of Cancer|September 16, 2010
The Role of F-FDG-Positron Emission Tomography/Computed Tomography in Staging Primary Breast CancerNaoki Niikura, Naoto T Ueno
Cancer Biomarkers : Section a of Disease Markers|June 6, 2013
Change in HER2 status during breast tumor progressionNaoki Niikura, Naoto T Ueno
Methods and Protocols|June 25, 2026
A Multiresolution Breast Cancer CIBERSORTx Resource Validated for Accuracy, Interpretive Limits, and Biological and Clinical Coherence in Tumor Microenvironment DeconvolutionToru Hanamura, Akinori Takase, Masanori Oshi, et al.
Japanese Journal of Clinical Oncology|October 17, 2014
Brain metastases in breast cancerNaoki Niikura, Shigehira Saji, Yutaka Tokuda, et al.
The Tokai Journal of Experimental and Clinical Medicine|December 10, 2020
Stability of HER2 Status by Dual-color in Situ Hybridization Before and After Neoadjuvant Chemotherapy in Breast CancerTakuho Okamura, Nobue Kumaki, Banri Tsuda, et al.
Clinical Breast Cancer|February 24, 2019
Impact of Subtype on Survival of Young Patients With Stage IV Breast CancerRin Ogiya, Yasuaki Sagara, Naoki Niikura, et al.
Breast Cancer Research and Treatment|November 28, 2012
Adding hormonal therapy to chemotherapy and trastuzumab improves prognosis in patients with hormone receptor-positive and human epidermal growth factor receptor 2-positive primary breast cancerNaoki Hayashi, Naoki Niikura, Hideko Yamauchi, et al.
The Tokai Journal of Experimental and Clinical Medicine|September 9, 2020
Students' Input on Preparing a Weekly Calendar of Individual Students in the Breast Surgery Clinical ClerkshipBanri Tsuda, Kozue Yokoyama, Mayako Terao, et al.
Breast (Edinburgh, Scotland)|September 2, 2025
Survival of patients with squamous cell carcinoma of the breast compared with invasive ductal carcinoma by biological subtype: A matched analysis of the Japanese national clinical database-breast cancer registryMami Ogita, Hiraku Kumamaru, Makoto Kubo, et al.
Pageof 13

Showing results (1-10 of 130) with videos related to

Sort By:
Pageof 13
Translational Cancer Research|February 4, 2022
Diagnosis of oligometastasisMayako Terao, Naoki Niikura
Journal of Cancer|September 16, 2010
The Role of F-FDG-Positron Emission Tomography/Computed Tomography in Staging Primary Breast CancerNaoki Niikura, Naoto T Ueno
Cancer Biomarkers : Section a of Disease Markers|June 6, 2013
Change in HER2 status during breast tumor progressionNaoki Niikura, Naoto T Ueno
Methods and Protocols|June 25, 2026
A Multiresolution Breast Cancer CIBERSORTx Resource Validated for Accuracy, Interpretive Limits, and Biological and Clinical Coherence in Tumor Microenvironment DeconvolutionToru Hanamura, Akinori Takase, Masanori Oshi, et al.
Japanese Journal of Clinical Oncology|October 17, 2014
Brain metastases in breast cancerNaoki Niikura, Shigehira Saji, Yutaka Tokuda, et al.
The Tokai Journal of Experimental and Clinical Medicine|December 10, 2020
Stability of HER2 Status by Dual-color in Situ Hybridization Before and After Neoadjuvant Chemotherapy in Breast CancerTakuho Okamura, Nobue Kumaki, Banri Tsuda, et al.
Clinical Breast Cancer|February 24, 2019
Impact of Subtype on Survival of Young Patients With Stage IV Breast CancerRin Ogiya, Yasuaki Sagara, Naoki Niikura, et al.
Breast Cancer Research and Treatment|November 28, 2012
Adding hormonal therapy to chemotherapy and trastuzumab improves prognosis in patients with hormone receptor-positive and human epidermal growth factor receptor 2-positive primary breast cancerNaoki Hayashi, Naoki Niikura, Hideko Yamauchi, et al.
The Tokai Journal of Experimental and Clinical Medicine|September 9, 2020
Students' Input on Preparing a Weekly Calendar of Individual Students in the Breast Surgery Clinical ClerkshipBanri Tsuda, Kozue Yokoyama, Mayako Terao, et al.
Breast (Edinburgh, Scotland)|September 2, 2025
Survival of patients with squamous cell carcinoma of the breast compared with invasive ductal carcinoma by biological subtype: A matched analysis of the Japanese national clinical database-breast cancer registryMami Ogita, Hiraku Kumamaru, Makoto Kubo, et al.
Pageof 13